L-Methionine-DL-sulfoximine
CAS No. 15985-39-4
L-Methionine-DL-sulfoximine( MSX | MSO )
Catalog No. M28359 CAS No. 15985-39-4
L-Methionine-DL-sulfoximine inhibits glutamine synthetase and metabolically and morphologically primarily affects astroglia. L-Methionine-DL-sulfoximine can be used in convulsant studies.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 33 | In Stock |
|
| 100MG | 47 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameL-Methionine-DL-sulfoximine
-
NoteResearch use only, not for human use.
-
Brief DescriptionL-Methionine-DL-sulfoximine inhibits glutamine synthetase and metabolically and morphologically primarily affects astroglia. L-Methionine-DL-sulfoximine can be used in convulsant studies.
-
DescriptionL-Methionine-DL-sulfoximine inhibits glutamine synthetase and metabolically and morphologically primarily affects astroglia. L-Methionine-DL-sulfoximine can be used in convulsant studies.
-
In Vitro——
-
In Vivo——
-
SynonymsMSX | MSO
-
PathwayOthers
-
TargetOther Targets
-
RecptorCCR8
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number15985-39-4
-
Formula Weight180.22
-
Molecular FormulaC5H12N2O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 50 mg/mL (277.42 mM)
-
SMILESCS(=N)(=O)CC[C@H](N)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
DCZ0415
DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-κB activity.DCZ0415 (10, 20 μM; 72 hours) showed a marked reduction in colony formation, indicating that it inhibited cell proliferation.
-
Cyclo(Ile-Val)
Cyclo(Ile-Val) shows moderate antifungal and weak antitumor activities in vitro.
-
DMAPP triammonium
DMAPP triammonium (Dimethylallyl diphosphate triammonium) is one of the prerequisite substances for an isoprenoid involved in the mevalonate (MVA) pathway, which can be used in the study of metabolism-related diseases.
Cart
sales@molnova.com